Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:08049's Days Inventory is ranked worse than 59.37% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs HKSE:08049: 186.52
Inventory Turnover measures how fast the company turns over its inventory within a year.
Jilin Province Huinan Changlong Bio-pharmacy Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Jilin Province Huinan Changlong Bio-pharmacy Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.17.
Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Jilin Province Huinan Changlong Bio-pharmacy Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Jilin Province Huinan Changlong Bio-pharmacy Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Jilin Province Huinan Changlong Bio-pharmacy Co Days Inventory Related Terms
Jilin Province Huinan Changlong Bio-pharmacy Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jilin Province Huinan Changlong Bio-pharmacy Co Days Inventory Chart
Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
HKSE:08049 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jilin Province Huinan Changlong Bio-pharmacy Co Days Inventory vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) has a Days Inventory of 220.51 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. This is 30% above median its historical median of 169.12. Over the past decade, Jilin Province Huinan Changlong Bio-pharmacy Co's Days Inventory has ranged from 76.75 to 214.63. According to the industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #548 out of 923 companies in the Drug Manufacturers industry, placing it in the top 59.4%.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's Days Inventory too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current Days Inventory of 220.51 is 30% above median its 10-year median of 169.12. Over the past 10 years, this metric has ranged from a low of 76.75 to a high of 214.63. The Drug Manufacturers industry median Days Inventory is 164.38. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 220.51 is 34.1% above this industry median. Based on the distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #548 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #548 out of 923 companies for Days Inventory. This places Jilin Province Huinan Changlong Bio-pharmacy Co in the lower half of its industry. The industry median Days Inventory is 164.38. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 220.51 is 34.1% above this benchmark. Historically, Jilin Province Huinan Changlong Bio-pharmacy Co's own Days Inventory has ranged from 76.75 to 214.63 over the past decade. While the company's 10-year median is 169.12 vs. the industry median of 164.38, Jilin Province Huinan Changlong Bio-pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jilin Province Huinan Changlong Bio-pharmacy Co's current Days Inventory of 220.51 is 34.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jilin Province Huinan Changlong Bio-pharmacy Co's current Days Inventory is 220.51, which is 30% above median its own 10-year median of 169.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$1.66, compared to a current price of HK$2.34 — trading 41% above its estimated fair value. The current Days Inventory is 220.51, which is 30% above median its 10-year median of 169.12 and 34.1% above the Drug Manufacturers industry median of 164.38. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049), the current Days Inventory is 220.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Overvalued in 2026?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued.
The current stock price of HK$2.34 is trading 41% above its estimated GF Value™ of HK$1.66.
GuruFocus considers Jilin Province Huinan Changlong Bio-pharmacy Co to be Significantly Overvalued.
Key valuation signals for HKSE:08049:
Days Inventory: 220.51 (30% above median its 10-year median of 169.12)
GF Value™: HK$1.66 vs. price of HK$2.34 (41% above fair value)
Industry Position: 34.1% above the Drug Manufacturers median (#548 of 923)
No single metric tells the full story. See the HKSE:08049 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jilin Province Huinan Changlong Bio-pharmacy Co Business Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
80GF Score
Get the complete analysis for HKSE:08049
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08049 has been successfully added to your 
